Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pericapsular Nerve Group Block in Total Hip Arthroplasty
NCT07449403Recruiting
- Sponsor
- Poznan University of Medical Sciences
- Start
- Mar 2026
- Primary completion
- Sep 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of ropivacaine in hip osteoarthritis (2 arms), sponsored by Poznan University of Medical Sciences. Primary endpoint: Systemic Inflammation Response Index at 12 hours. Started Mar 2026; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on NCT07449403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07449403.